Predicting heart function using echocardiography and body composition data
AI-based Prediction of Cardiac Function Using Echocardiography and Body Composition Data (ECHO-FIT Study)
This study is testing if combining heart ultrasound results with body composition data can help predict heart function in people with and without heart failure.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2000 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Yonsei University Academic / other |
| Locations | 1 site (Yongin, Gyeonggi-do) |
| Trial ID | NCT06811519 on ClinicalTrials.gov |
What this trial studies
This observational study aims to develop and validate a predictive model for cardiac function, specifically left ventricular ejection fraction (LVEF), by combining echocardiographic measurements with body composition data from the QCCUNIQ BC 720 device. It will enroll 2,000 adult participants, half with normal LVEF and half with heart failure, to undergo standard echocardiography and body composition analysis. The study seeks to analyze the relationships between echocardiographic parameters and body composition measures to create a non-invasive prediction model for identifying individuals at higher risk of cardiac dysfunction.
Who should consider this trial
Good fit: Ideal candidates are adults aged 20 years or older who are undergoing routine echocardiography.
Not a fit: Patients with physical or mental conditions that prevent them from undergoing echocardiography or body composition analysis may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could enhance early detection and personalized management of heart failure.
How similar studies have performed: Other studies have shown promise in using similar approaches to integrate echocardiographic and body composition data, but this specific model is novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Aged 20 years or older. * Undergoing a standard echocardiographic examination. * Providing consent to undergo body composition analysis. * Signing the informed consent form to voluntarily participate in the study. Exclusion Criteria: * Having a physical or mental condition that makes it impossible to conduct an echocardiogram or perform body composition analysis. * Deemed inappropriate for study participation by the researcher (e.g., unable to cooperate).
Where this trial is running
Yongin, Gyeonggi-do
- Yongin Severance Hospital — Yongin, Gyeonggi-do, South Korea (Recruiting)
Study contacts
- Principal investigator: In Hyun Jung, MD., PhD. — Severance Hospital
- Study coordinator: SungA Bae, MD., PhD.
- Email: cardiobsa@yuhs.ac
- Phone: 01023273578
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.